Z86.007

Clinical Causes: Ultraviolet (UV) radiation exposure from sun or tanning beds Chronic skin irritation or inflammation Repeated skin injury or scarring Genetic predisposition to skin abnormalities Exposure to certain chemicals or carcinogens Immunosuppression or weakened immune system History of other skin cancers

Key Symptoms: Appearance of new or changing skin lesions Skin patches that are red, brown, or flesh-colored Premalignant spots that do not heal Lesions that may be rough, scaly, or slightly elevated In some cases, no visible symptoms, detected only through screening or biopsy

Diagnosis Path: Diagnosis of an in-situ neoplasm of the skin involves a thorough skin examination and histological analysis. A healthcare professional may perform a biopsy—removing a small sample of the affected skin for laboratory testing—to confirm the presence of abnormal, pre-cancerous cells. Additional diagnostic tools may include dermoscopy, which uses a specialized microscope to evaluate skin lesions more clearly. Proper diagnosis helps determine the extent of the neoplasm and guides treatment options.

Treatment Protocols: Treatment strategies for in-situ skin neoplasms aim to remove abnormal cells and prevent progression to invasive cancer. Common approaches include: - Surgical excision to physically remove the lesion - Cryotherapy, which involves freezing the abnormal cells - Topical medications like fluorouracil or imiquimod to eradicate abnormal cells - Photodynamic therapy using light-sensitive drugs and light exposure - Curettage and electrodessication for superficial lesions Follow-up care is essential to monitor for any signs of recurrence or new lesions, especially in patients with a history of skin neoplasms. Preventive measures such as sun protection and regular skin checks are recommended to reduce the risk of future skin abnormalities.